GreenLight Biosciences, Inc.
GreenLight Biosciences, Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in RNA-based solutions for agriculture and human health. Founded in 2008, the company has made significant strides in developing innovative products that leverage the power of RNA to enhance crop protection and improve plant health. With a focus on sustainable agriculture, GreenLight's core offerings include RNA interference (RNAi) technology, which provides a unique approach to pest control and disease management. This technology sets them apart in the market, as it offers environmentally friendly alternatives to traditional chemical pesticides. Recognised for its commitment to sustainability and innovation, GreenLight Biosciences has positioned itself as a leader in the agricultural biotechnology industry, contributing to a more sustainable future while addressing the growing global demand for food security.
DitchCarbon Score
How does GreenLight Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GreenLight Biosciences, Inc.'s score of 5 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GreenLight Biosciences, Inc.'s reported carbon emissions
In 2022, GreenLight Biosciences, Inc. reported total carbon emissions of approximately 4,353,000 kg CO2e. This figure includes Scope 1 emissions of about 658,000 kg CO2e and Scope 2 emissions, calculated on a location-based method, of approximately 3,695,000 kg CO2e. Currently, there are no publicly disclosed reduction targets or climate pledges from the company, indicating a potential area for future commitment. As a biotechnology firm headquartered in the US, GreenLight Biosciences operates within an industry increasingly focused on sustainability and reducing carbon footprints. Their emissions data highlights the importance of addressing both direct and indirect emissions to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | |
|---|---|
| Scope 1 | 658,000 |
| Scope 2 | 3,695,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GreenLight Biosciences, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
